CV Sciences CVSI
OTC CVSI
$0.02 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

CV Sciences (CVSI) Total Non-Current Liabilities (2013 - 2026)

CV Sciences (CVSI) posted Total Non-Current Liabilities of $5.2 million for Q1 2026, down 4.91% sequentially from $5.5 million in Q4 2025, and down 10.99% YoY from $5.9 million in Q1 2025.

CV Sciences (CVSI) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

CV Sciences has reported Total Non-Current Liabilities for 11 years, with the latest figure at $5.2 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 10.99% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 10.99% YoY) and the FY2025 annual result came in at $5.5 million, down 10.4% from the prior year.
  • Total Non-Current Liabilities slipped to $5.2 million in Q1 2026 per CVSI's latest filing, from $5.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $13.5 million in Q4 2022 and troughed at $5.2 million in Q1 2026.
  • A 5-year average of $6.6 million and a median of $6.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities tumbled 54.18% in 2023, then dropped 0.97% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $13.5 million in 2022, then sank by 54.18% to $6.2 million in 2023, then dropped by 0.97% to $6.1 million in 2024, then slipped by 10.4% to $5.5 million in 2025, then declined by 4.91% to $5.2 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $5.2 million, $5.5 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 334.00 Mn
10 CV Sciences 4.10 Mn 3.84 Mn 1.45 Mn 4.95 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.95 Mn
Mar 31, 2026 5.22 Mn
Dec 31, 2025 5.49 Mn
Sep 30, 2025 5.46 Mn
Jun 30, 2025 6.15 Mn
Mar 31, 2025 5.87 Mn
Dec 31, 2024 6.13 Mn
Sep 30, 2024 6.16 Mn
Jun 30, 2024 6.28 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 6.19 Mn
Dec 31, 2022 13.51 Mn
Dec 31, 2020 19.41 Mn
Sep 30, 2020 18.96 Mn
Jun 30, 2020 23.71 Mn
Mar 31, 2020 21.94 Mn
Dec 31, 2019 23.13 Mn
Sep 30, 2019 23.00 Mn
Jun 30, 2019 17.37 Mn
Mar 31, 2019 17.08 Mn